Liang & Hennessey LLP is pleased to represent Backpacks for Life pro bono. Check out their Bowery Pack at www.backpacksforlife.org.
Stanley Liang filed a petition for certiorari in the U.S. Supreme Court in August 2018. The petition, ultimately not granted, relates to the scope of patentable subject matter under 35 U.S.C. s. 101. The petition highlights the tension between two Supreme Court decisions: Funk Bros., which articulates a more restrictive standard, and Myriad, which articulates a less restrictive standard. The petition also points out the need for a court to provide truly meaningful review when it reviews a PTAB decision. Links to the petition and appendix (which include copies of the decisions below) are provided here.
Appendix to cert. petition
Stanley Liang spoke at the NJIPLA 28th Annual Pharmaceutical / Chemical Patent Practice Update. The topic of his talk is Use of AIA Post-Grant Proceedings by Defendants in Hatch-Waxman Litigation.
Stanley Liang filed an amicus brief in Amgen Inc. et al. v. Sanofi et al. in the Court of Appeals for the Federal Circuit, which has been entered into the record on July 2, 2020.